SPANXD
gene geneOn this page
Also known as CT11.4
Summary
SPANXD (SPANX family member D, HGNC:14332) is a protein-coding gene on chromosome Xq27.2, encoding Sperm protein associated with the nucleus on the X chromosome D (Q9BXN6).
Temporally regulated transcription and translation of several testis-specific genes is required to initiate the series of molecular and morphological changes in the male germ cell lineage necessary for the formation of mature spermatozoa. This gene is a member of the SPANX family of cancer/testis-associated genes, which are located in a cluster on chromosome X. The SPANX genes encode differentially expressed testis-specific proteins that localize to various subcellular compartments. This particular gene encodes a sperm protein that is associated with the nucleus but, although a role in spermatogenesis is suggested, the specific function of this family member has not yet been determined. Polymorphisms in this gene may be associated with prostate cancer susceptibility.
Source: NCBI Gene 64648 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 39 total
- MANE Select transcript:
NM_032417
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14332 |
| Approved symbol | SPANXD |
| Name | SPANX family member D |
| Location | Xq27.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CT11.4 |
| Ensembl gene | ENSG00000196406 |
| Ensembl biotype | protein_coding |
| OMIM | 300670 |
| Entrez | 64648 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000370515
RefSeq mRNA: 1 — MANE Select: NM_032417
NM_032417
CCDS: CCDS14675
Canonical transcript exons
ENST00000370515 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001826931 | 141698334 | 141698739 |
| ENSE00001930437 | 141697411 | 141697686 |
Expression profiles
Bgee: expression breadth broad, 17 present calls, max score 83.12.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0315 / max 8.5181, expressed in 11 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 200747 | 0.0315 | 11 |
Top tissues by expression
117 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.12 | gold quality |
| right testis | UBERON:0004534 | 82.95 | gold quality |
| left testis | UBERON:0004533 | 82.61 | gold quality |
| testis | UBERON:0000473 | 82.21 | gold quality |
| sural nerve | UBERON:0015488 | 45.90 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| bone marrow | UBERON:0002371 | 33.15 | gold quality |
| primary visual cortex | UBERON:0002436 | 31.84 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| placenta | UBERON:0001987 | 29.45 | gold quality |
| lymph node | UBERON:0000029 | 29.15 | gold quality |
| tonsil | UBERON:0002372 | 28.81 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| urinary bladder | UBERON:0001255 | 27.78 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 26.48 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| omental fat pad | UBERON:0010414 | 26.42 | gold quality |
| leukocyte | CL:0000738 | 26.38 | gold quality |
| monocyte | CL:0000576 | 26.26 | gold quality |
| blood | UBERON:0000178 | 26.14 | gold quality |
| muscle of leg | UBERON:0001383 | 26.09 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.98 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- High SPANXD expression is associated with breast cancer invasion. (PMID:26895102)
Cross-species orthologs
0 orthologs
Paralogs (4): SPANXA1 (ENSG00000198021), SPANXC (ENSG00000198573), SPANXA2 (ENSG00000203926), SPANXB1 (ENSG00000227234)
Protein
Protein identifiers
Sperm protein associated with the nucleus on the X chromosome D — Q9BXN6 (reviewed: Q9BXN6)
Alternative names: Cancer/testis antigen 11.4, Nuclear-associated protein SPAN-Xd, SPANX family member D
All UniProt accessions (1): Q9BXN6
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Cytoplasm. Nucleus.
Tissue specificity. Detected in testis, sperm and a melanoma cell line.
Similarity. Belongs to the SPAN-X family.
RefSeq proteins (1): NP_115793* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR010007 | SPAN-X_fam | Family |
Pfam: PF07458
UniProt features (4 total): chain 1, region of interest 1, short sequence motif 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BXN6-F1 | 69.81 | 0.08 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 4 (showing top):
ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, LU_EZH2_TARGETS_UP, chrXq27, FORTSCHEGGER_PHF8_TARGETS_DN
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): nucleus (GO:0005634), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
464 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPANXD | SPANXN4 | Q5MJ08 | 655 |
| SPANXD | SRY | Q05066 | 653 |
| SPANXD | SPANXN3 | Q5MJ09 | 583 |
| SPANXD | GAGE2A | Q6NT46 | 573 |
| SPANXD | XAGE2 | Q96GT9 | 570 |
| SPANXD | LGALS4 | P56470 | 549 |
| SPANXD | GAGE4 | P0DSO3 | 540 |
| SPANXD | FATE1 | Q969F0 | 506 |
| SPANXD | MAGEB2 | O15479 | 479 |
| SPANXD | XAGE1B | Q9HD64 | 479 |
| SPANXD | FMR1NB | Q8N0W7 | 478 |
| SPANXD | RNF225 | M0QZC1 | 476 |
| SPANXD | SPA17 | Q15506 | 453 |
| SPANXD | MAGEC3 | Q8TD91 | 447 |
| SPANXD | MAGEA4 | P43358 | 446 |
IntAct
13 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SPANXD | SETBP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SETBP1 | SPANXD | psi-mi:“MI:0915”(physical association) | 0.560 |
| FLNA | SPANXD | psi-mi:“MI:0915”(physical association) | 0.560 |
| CSAG1 | NAP1L4 | psi-mi:“MI:0914”(association) | 0.350 |
| CSAG2 | CAMK2D | psi-mi:“MI:0914”(association) | 0.350 |
| SPANXB1 | PAPSS2 | psi-mi:“MI:0914”(association) | 0.350 |
| SPANXD | FLNA | psi-mi:“MI:0915”(physical association) | 0.000 |
| SPANXD | SETBP1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (6): SPANXD (Two-hybrid), SPANXD (Two-hybrid), SPANXD (Two-hybrid), FLNA (Two-hybrid), SPANXD (Affinity Capture-MS), SPANXD (Affinity Capture-MS)
ESM2 similar proteins: A0A1B0GTR3, A0A7H0DN82, A7RR34, E9PVX6, O14598, O60356, O60829, O94243, P04605, P04614, P05909, P0C1K0, P0C765, P0C766, P0DPH9, P17285, P17759, P18098, P19416, P20290, P24109, P46012, P46583, Q06428, Q07555, Q08561, Q09821, Q1L9C7, Q32PF3, Q3KP22, Q5M948, Q5M951, Q5MJ08, Q5RCI9, Q6P8I4, Q758T8, Q76632, Q7M2N1, Q7TP40, Q80WR5
Diamond homologs: Q0ZNK1, Q5MJ07, Q5MJ08, Q5MJ09, Q5MJ10, Q5VSR9, Q6SJ82, Q6SJ84, Q6SJ91, Q9BXN6, Q9NS26, Q9NY87, Q9NS25
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
39 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 36 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
242 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:141697460:T:TA | donor_gain | 1.0000 |
| X:141697493:T:TA | donor_gain | 1.0000 |
| X:141697502:T:TA | donor_gain | 1.0000 |
| X:141697505:T:TA | donor_gain | 1.0000 |
| X:141697508:T:TA | donor_gain | 1.0000 |
| X:141698328:TCTTA:T | donor_loss | 1.0000 |
| X:141698329:CTTAC:C | donor_loss | 1.0000 |
| X:141698330:TTA:T | donor_loss | 1.0000 |
| X:141698331:TACC:T | donor_loss | 1.0000 |
| X:141698332:A:AC | donor_gain | 1.0000 |
| X:141698332:A:AT | donor_loss | 1.0000 |
| X:141698333:C:CC | donor_gain | 1.0000 |
| X:141698333:C:CT | donor_loss | 1.0000 |
| X:141698333:CCAT:C | donor_gain | 1.0000 |
| X:141697437:G:A | donor_gain | 0.9900 |
| X:141697457:G:C | donor_gain | 0.9900 |
| X:141697462:TTGC:T | donor_gain | 0.9900 |
| X:141697463:TGCT:T | donor_gain | 0.9900 |
| X:141697465:C:CT | donor_gain | 0.9900 |
| X:141697466:T:TT | donor_gain | 0.9900 |
| X:141697490:ATTT:A | donor_gain | 0.9900 |
| X:141697685:G:GG | acceptor_gain | 0.9900 |
| X:141697686:A:AG | acceptor_gain | 0.9900 |
| X:141698314:TCAGA:T | donor_gain | 0.9900 |
| X:141698331:TACCA:T | donor_loss | 0.9900 |
| X:141697511:T:TA | donor_gain | 0.9800 |
| X:141697684:CAT:C | acceptor_gain | 0.9800 |
| X:141697685:G:GT | acceptor_loss | 0.9800 |
| X:141697685:GAT:G | acceptor_gain | 0.9800 |
| X:141697686:A:T | acceptor_loss | 0.9800 |
AlphaMissense
645 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:141697498:G:C | F87L | 0.895 |
| X:141697498:G:T | F87L | 0.895 |
| X:141697500:A:G | F87L | 0.895 |
| X:141697490:A:G | I90T | 0.686 |
| X:141697601:A:T | V53D | 0.650 |
| X:141697588:C:A | R57S | 0.645 |
| X:141697588:C:G | R57S | 0.645 |
| X:141697529:A:G | I77T | 0.615 |
| X:141698358:A:C | C16W | 0.613 |
| X:141697591:C:A | R56S | 0.611 |
| X:141697591:C:G | R56S | 0.611 |
| X:141697525:G:C | N78K | 0.597 |
| X:141697525:G:T | N78K | 0.597 |
| X:141697579:T:A | K60N | 0.596 |
| X:141697579:T:G | K60N | 0.596 |
| X:141697490:A:T | I90K | 0.581 |
| X:141697534:G:C | N75K | 0.565 |
| X:141697534:G:T | N75K | 0.565 |
dbSNP variants (sampled 300 via entrez): RS1059178 (X:141697584 A>C), RS1059179 (X:141697582 A>C,G), RS1157205174 (X:141699681 C>T), RS1157228969 (X:141700535 G>A), RS1157706476 (X:141699137 A>G), RS1157863049 (X:141698383 C>G,T), RS1158154323 (X:141697014 C>G), RS1159199976 (X:141698781 C>A), RS1159568611 (X:141699439 C>A,G,T), RS1160089617 (X:141697999 C>T), RS1160807415 (X:141699734 A>T), RS1161012211 (X:141700603 T>G), RS1162471886 (X:141697264 C>A), RS1162886839 (X:141699370 T>A), RS1163057030 (X:141700474 GT>G,GTT)
Disease associations
OMIM: gene MIM:300670 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases expression | 2 |
| Benzo(a)pyrene | decreases methylation, increases expression | 2 |
| methylmercuric chloride | increases expression | 1 |
| maleic acid | increases expression | 1 |
| cupric oxide | increases expression | 1 |
| mercuric bromide | increases expression | 1 |
| clothianidin | increases expression | 1 |
| Resveratrol | increases expression | 1 |
| Decitabine | increases expression | 1 |
| Air Pollutants | increases expression | 1 |
| Cadmium | decreases expression | 1 |
| Plant Oils | increases expression | 1 |
| Valproic Acid | increases expression | 1 |
| Aflatoxin B1 | increases expression | 1 |
| Copper Sulfate | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.